0.2921
price up icon3.29%   +0.0093
after-market  After Hours:  .293  0.0009   +0.31%
loading
Aclarion Inc stock is currently priced at $0.2921, with a 24-hour trading volume of 340.15K. It has seen a +3.29% increased in the last 24 hours and a -9.54% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.2879 pivot point. If it approaches the $0.2949 resistance level, significant changes may occur.
Previous Close:
$0.2828
Open:
$0.3
24h Volume:
340.15K
Market Cap:
$2.09M
Revenue:
$75,400
Net Income/Loss:
$-4.91M
P/E Ratio:
-0.5216
EPS:
-0.56
Net Cash Flow:
$-3.77M
1W Performance:
-13.32%
1M Performance:
-9.54%
6M Performance:
-12.10%
1Y Performance:
-65.64%
1D Range:
Value
$0.2845
$0.30
52W Range:
Value
$0.1811
$6.75

Aclarion Inc Stock (ACON) Company Profile

Name
Name
Aclarion Inc
Name
Phone
650-241-1741
Name
Address
951 Mariners Island Boulevard, Suite 300, San Mateo
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ACON's Discussions on Twitter

Aclarion Inc Stock (ACON) Financials Data

Aclarion Inc (ACON) Revenue 2024

ACON reported a revenue (TTM) of $75.40 thousand for the quarter ending December 31, 2023, a +24.83% rise year-over-year.
loading

Aclarion Inc (ACON) Net Income 2024

ACON net income (TTM) was -$4.91 million for the quarter ending December 31, 2023, a +30.52% increase year-over-year.
loading

Aclarion Inc (ACON) Cash Flow 2024

ACON recorded a free cash flow (TTM) of -$3.77 million for the quarter ending December 31, 2023, a +26.98% increase year-over-year.
loading

Aclarion Inc (ACON) Earnings per Share 2024

ACON earnings per share (TTM) was -$8.98 for the quarter ending December 31, 2023, a +38.27% growth year-over-year.
loading
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
$17.60
price down icon 0.06%
$31.72
price down icon 1.09%
health_information_services EVH
$27.10
price down icon 1.13%
health_information_services TXG
$27.48
price up icon 4.53%
$24.09
price down icon 0.95%
health_information_services RCM
$12.47
price up icon 0.16%
Cap:     |  Volume (24h):